Joint CINP/Brain Symposium on Difficult to Treat Depression
2024年5月24日(金) 15:00 〜 16:15
Room 3 (Hall D7)
Chair: Joseph Zohar (National Post-Trauma Center, Research Foundation by the Sheba Medical Center, Israel)
Symposium 1
Risk and Resilience in PTSD: Analyzing Trajectories and New Treatment Approaches
2024年5月24日(金) 10:45 〜 12:00
Room 1 (Hall C)
Chair: Eric Vermetten (Leiden University Medical Center, Leiden, The Netherlands)
Symposium 2
Time for a serotonin rethink: new discoveries in serotonin neuron heterogeneity
2024年5月24日(金) 10:45 〜 12:00
Room 2 (Hall B7 (1))
Chair: Yu Ohmura (Chinese Institute for Brain Research (CIBR))
Symposium 3
Targeting Autoantibodies: A Precision Medicine Approach in Psychotic Disorders
2024年5月24日(金) 10:45 〜 12:00
Room 3 (Hall D7)
Chair: Belinda Lennox (University of Oxford)
Symposium 4
Targeting neural circuits for therapeutic intervention in altered salience and reward related psychiatric conditions
2024年5月24日(金) 10:45 〜 12:00
Room 4 (Hall D1)
Chair: Huai-Hsuan Tseng (National Cheng Kung University)
Symposium 5
Optimizing repetitive transcranial magnetic stimulation therapies for depression and addiction: challenges and pitfalls
2024年5月24日(金) 10:45 〜 12:00
Room 5 (G409)
Chair: Georg S. Kranz (Medical University of Vienna, Vienna, Austria)
Symposium 6
Novel therapies to treat bipolar disorder: translation and back-translation between preclinical and clinical studies
2024年5月24日(金) 13:30 〜 14:45
Room 1 (Hall C)
Chair: Michael Berk (Deakin University)
Symposium 7
Decoding Ketamine's Enigma: Unravelling the role of specific NMDA Receptor Subunits in its antidepressant and cognitive functions.
2024年5月24日(金) 13:30 〜 14:45
Room 2 (Hall B7 (1))
Chair: Rachel A. Hill (Monash University)
Symposium 8
The impact of early life adversity on brain and behavior
2024年5月24日(金) 13:30 〜 14:45
Room 3 (Hall D7)
Chair: Zijun Wang (University of Kansas)
Symposium 9
Sociability, Motivation and Pleasure in mental disorders: From molecular understanding to therapeutic strategies.
2024年5月24日(金) 13:30 〜 14:45
Room 4 (Hall D1)
Chair: Marco A. Riva (University of Milan), Eri Hashimoto (Sapporo Medical University)
Symposium 10
The antidepressant effect and mode of action of psilocybin - clinical trial and molecular imaging data from studies in man and pig
2024年5月25日(土) 10:10 〜 11:25
Room 1 (Hall C)
Chair: Johan Lundberg (Karolinska Institutet)
Symposium 11
Understanding molecular, cellular, and circuit mechanisms and development of therapeutic methods for PTSD
2024年5月25日(土) 10:10 〜 11:25
Room 2 (Hall B7 (1))
Chair: Satoshi Kida (The University of Tokyo)
Symposium 12
Digital phenotype to guide clinical interventions for suicide treatment
2024年5月25日(土) 10:10 〜 11:25
Room 3 (Hall D7)
Chair: Enrique Baca-Garcia (Fundacion Jimenez Diaz. Universidad Autonoma de Madrid), Fuensanta Aroca (Universidad Nacional Autónoma de Mexico)
Symposium 13
Improving Outcomes in Mental Illness: From Neuroimaging and Digital Technology to Implementation Science
2024年5月25日(土) 10:10 〜 11:25
Room 4 (Hall D1)
Chair: John M. Kane (Donald and Barbara Zucker School of Medicine at Hofstra/Northwell)
Symposium 14
Understanding the Mechanisms of Social Stress and Autism-linked Social Deficits
2024年5月25日(土) 10:10 〜 11:25
Room 5 (G409)
Chair: Zhen Yan (State University of New York at Buffalo)
Symposium 15
New Insights on Cannabis Use and Clinical Implications: Translational Perspective
2024年5月25日(土) 13:00 〜 14:15
Room 1 (Hall C)
Chair: Deepak C D'Souza (Yale University)
Symposium 16
Targeting Neurotransmitter Systems in Addiction: Advances and Future Directions
2024年5月25日(土) 13:00 〜 14:15
Room 2 (Hall B7 (1))
Chair: Kazutaka Ikeda (Tokyo Metropolitan Institute of Medical Science)
Symposium 17
Identifying and fixing dysfunctional circuits in depression: leveraging systems neuroscience and translational approaches for developing novel targets and therapeutics.
2024年5月25日(土) 13:00 〜 14:15
Room 3 (Hall D7)
Chair: Satoshi Kida (The University of Tokyo)
Symposium 18
Sex differences in psychiatric disorders: from molecular neurobiology to therapeutic strategies
2024年5月25日(土) 13:00 〜 14:15
Room 4 (Hall D1)
Chair: Marin Veldic (Department of Psychiatry and Psychology, Mayo Clinic)
Symposium 19
Predicting and quantifying treatment response to drugs for psychosis and symptom severity in schizophrenia using machine learning
2024年5月25日(土) 14:30 〜 15:45
Room 5 (G409)
Chair: Søren Dinesen Østergaard (Department of Psychiatry, Aarhus University Hospital, Aarhus, Denmark)
Symposium 20
Dysfunction of Glutamate, Dopamine, and GABA Neurotransmission in Schizophrenia: Integrative View for Pathophysiologic Analysis and Innovative Treatment
2024年5月26日(日) 10:45 〜 12:00
Room 1 (Hall C)
Chair: Toru Nishikawa (Showa Medical University/Kyoto Prefectural University of Medicine)
Symposium 21
Late-Life Treatment Resistant Depression: Advances in pharmacotherapy, brain stimulation, and brain-based mechanisms of treatment response variability.
2024年5月26日(日) 10:45 〜 12:00
Room 2 (Hall B7 (1))
Chair: Jordan F Karp (Tucson, University of Arizona)
Symposium 22
Multi-modal Approaches to Identify Novel Mitochondria-Based Strategies to the Diagnosis and Treatment Mood Disorders
2024年5月26日(日) 10:45 〜 12:00
Room 4 (Hall D1)
Chair: Hilary P Blumberg (Yale School of Medicine)
Symposium 23
Multi-omics approaches to understand the biological mechanisms of mood disorders
2024年5月26日(日) 10:45 〜 12:00
Room 5 (G409)
Chair: Niamh Mullins (Icahn School of Medicine at Mount Sinai)
Symposium 24
Cognitive Inflexibility: Transdiagnostic Clinical Syndromes, Endophenotype, and Response to Neurostimulation and Pharmacological Treatment
2024年5月26日(日) 10:45 〜 12:00
Room 10 (G402)
Chair: Eric Hollander (Albert Einstein College of Medicine)